Your browser doesn't support javascript.
loading
Assessing the arrhythmogenic propensity of fibrotic substrate using digital twins to inform a mechanisms-based atrial fibrillation ablation strategy.
Sakata, Kensuke; Bradley, Ryan P; Prakosa, Adityo; Yamamoto, Carolyna A P; Ali, Syed Yusuf; Loeffler, Shane; Tice, Brock M; Boyle, Patrick M; Kholmovski, Eugene G; Yadav, Ritu; Sinha, Sunil Kumar; Marine, Joseph E; Calkins, Hugh; Spragg, David D; Trayanova, Natalia A.
Afiliação
  • Sakata K; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
  • Bradley RP; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
  • Prakosa A; Research Computing, Lehigh University, Bethlehem, PA, USA.
  • Yamamoto CAP; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
  • Ali SY; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
  • Loeffler S; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
  • Tice BM; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
  • Boyle PM; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
  • Kholmovski EG; Center for Cardiovascular Biology, University of Washington, Seattle, WA, USA.
  • Yadav R; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
  • Sinha SK; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
  • Marine JE; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
  • Calkins H; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Spragg DD; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Trayanova NA; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nat Cardiovasc Res ; 3(7): 857-868, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39157719
ABSTRACT
Atrial fibrillation (AF), the most common heart rhythm disorder, may cause stroke and heart failure. For patients with persistent AF with fibrosis proliferation, the standard AF treatment-pulmonary vein isolation-has poor outcomes, necessitating redo procedures, owing to insufficient understanding of what constitutes good targets in fibrotic substrates. Here we present a prospective clinical and personalized digital twin study that characterizes the arrhythmogenic properties of persistent AF substrates and uncovers locations possessing rotor-attracting capabilities. Among these, a portion needs to be ablated to render the substrate not inducible for rotors, but the rest (37%) lose rotor-attracting capabilities when another location is ablated. Leveraging digital twin mechanistic insights, we suggest ablation targets that eliminate arrhythmia propensity with minimum lesions while also minimizing the risk of iatrogenic tachycardia and AF recurrence. Our findings provide further evidence regarding the appropriate substrate ablation targets in persistent AF, opening the door for effective strategies to mitigate patients' AF burden.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article